Related Topics
Vaccine researcher Kizzmekia Corbett wins top honor for federal service
Harvard Chan School's Kizzmekia Corbett has been named a “Federal Employee of the Year” for conducting groundbreaking vaccine research while working at the National Institutes of Health.
How to pick which booster shot to get
Harvard Chan School's Asaf Bitton offered advice on choosing a COVID-19 vaccine booster.
Improving the conditions of work for vulnerable populations
Since 2007, the mission of the Center for Work, Health, & Well-being at Harvard T.H. Chan School of Public Health has been to identify and promote the workplace policies, programs, and practices that foster safe and healthy working…
Opinion: Fix crumbling school infrastructure
School buildings are in desperate need of repair, particularly of their systems that manage indoor air quality, according to an opinion piece co-authored by Harvard Chan School's Joseph Allen.
Weighing benefit vs. risk of newly authorized e-cig products
Three Harvard Chan School experts weigh in on the FDA’s decision to authorize a set of three e-cigarette products for sale in the U.S. for the first time.
Poll: As the Delta variant continues, 38% of U.S. households report facing serious financial problems in the past few months, despite two-thirds receiving government assistance
According to a new NPR/Robert Wood Johnson Foundation/Harvard Chan School poll, 38% of U.S. households report facing serious financial problems in the past few months, as the Delta variant outbreak has extended health and economic problems.
How to trick-or-treat safely during the pandemic
The Centers for Disease Control and Prevention has said it’s OK for kids to go trick-or-treating this Halloween—carefully.
Coronavirus (COVID-19): Press Conference with Michael Mina, 10/06/21
You're listening to a press conference from the Harvard T.H. Chan School of Public Health with Michael Mina, assistant professor of epidemiology and a faculty member in the Center for Communicable Disease Dynamics. This call was recorded at…
Price for experimental COVID-19 treatment raises concerns
A five-day course of medication that has shown promise treating COVID-19 is estimated to cost $17.74 to produce, but pharmaceutical firm Merck plans to charge the U.S. government $712, according to news reports. A recent study found that…
Questioning our reliance on cloth masks
Cloth masks are widely used in the U.S., but some experts say surgical masks could offer better protection against COVID-19.